Industry News
Further Tests To Determine The Efficacy Of The Drug Nivolumab For Lung Cancer
Jun 03, 2013
A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center presented at the 49th Annual Meeting of the American Society of Clinical Oncology... Read More
Discovery Of Possible Key To Cause Of Cushing Disease
Jun 03, 2013
Cushing disease is a life-threatening disorder most commonly triggered by tumors, often benign, in the pituitary glands, resulting in excess production of adrenocorticotrophic hormone (ACTH)... Read More
Many Solid Tumors Carry Genetic Changes Targeted By Existing Compounds
Jun 03, 2013
Nearly two-thirds of solid tumors carry at least one mutation that may be targeted, or medicated, by an existing compound, according to new findings from researchers Fox Chase Cancer Center that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology on June 3... Read More
Seeking A Less Toxic Radiation Treatment For HPV-Positive Oropharynx Cancer
Jun 03, 2013
Researchers from Fox Chase Cancer Center and other institutions have completed a phase II clinical trial that may help identify those patients with HPV-positive oropharyngeal cancer who do not require the full radiation dose given in a standard regimen of Intensity-Modulated Radiation Therapy (IMRT)... Read More
Narrowing The Search For Biomarkers Of Drug Resistance In Head And Neck Cancer Patients
Jun 03, 2013
Researchers from Fox Chase Cancer Center presented data at the 49th Annual Meeting of the American Society of Clinical Oncology which shows the discovery of potential biomarkers that may be used to identify patients with head and neck cancer whose tumors are unlikely to respond to treatment by the targeted therapy cetuximab - a type of monoclonal antibody... Read More
A Targeted Beam Of Energy Directed At Painful Sites Of Bone Metastases Can Cause Relief Within Days
Jun 03, 2013
A high-dose of ultrasound targeted to painful bone metastases appears to quickly bring patients relief, and with largely tolerable side effects, according to new research presented by Fox Chase Cancer Center scientists at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3... Read More
Mastectomy Often The First Choice For Young Breast Cancer Patients
Jun 03, 2013
A new study of young women with breast cancer has found that most chose to have a mastectomy rather than a surgical procedure that would conserve the breast, researchers report at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31-June 4, in Chicago... Read More
RNA Aptamer A Potential New Weapon In Fight Against Cervical Cancer
Jun 03, 2013
Scientists at the University of Leeds have found a way to target and destroy a key protein associated with the development of cervical and other cancers. The E7 protein is produced early in the lifecycle of the human papillomavirus (HPV) and blocks the body's natural defences against the uncontrolled division of cells that can lead to cancer... Read More
Funding Cuts Could Halt Advances Against Cancer
Jun 03, 2013
The rate of advances in clinical cancer research could stagnate after the recent cuts to biomedical research funding in the United States, warns ASCO President, President Sandra M. Swain, MD, FACP, in a briefing of the Society's 49th Annual Meeting in Chicago, Illinois... Read More
Insight Into Key Protein Linked To Development Of Cancers And Neurodegenerative Disorders
Jun 03, 2013
Virginia Commonwealth University researchers studying a key molecular player called Hsp70 that is responsible for protein homeostasis have uncovered how it binds together with another molecule responsible for intracellular energy transfer to enhance its overall activity and efficiency - details that have previously not been well understood... Read More
Previous Page Next Page
